PROGRAM

Logo of Kuopio Alzheimer Suymposium - brain drawing on turquoise background

9th Kuopio Alzheimer Symposium and
3rd Nordic Memory Clinic Conference
August 23–25, 2022

The 9th Alzheimer Symposium will be organized together with the 3rd Nordic Memory Clinic Conference.

Download the program in PDF:
9th Kuopio Alzheimer Symposium and 3rd Nordic Memory Clinic Conference – NMCC 23.8.–24.8.2022 (pdf) (updated 15.8.2022)

Abstract book of the 9th Kuopio Alzheimer Symposium: http://urn.fi/URN:ISBN:978-952-61-3817-6

The program in the abstract book might not be the latest version. The up to date version of the program is found on our website.


Day 1 – Tuesday, 23.8.2022:
3rd Nordic Memory Clinic Conference – NMCC

Opening and Session I: Advances in Alzheimer’s disease

Chairpersons: Anne Koivisto and Jon Snaedal

Time slotPresentation title
09.00–09.10Welcome
Anne Koivisto, Chairperson of the local NMCC Organising Committee and Jon Snaedal, Chair,
Nordic Network in Dementia Diagnostics
09.10–09.25Opening words
Sirpa Pietikäinen, Member of the European Parliament, Member of the Board of Alzheimer Europe
09.25–09.50New perspectives on the pathogenesis of AD
Heikki Tanila, University of Eastern Finland, Kuopio, Finland
09.50–10.20Q-EEG as novel technique in prognosis and differential diagnostic of cognitive impairment
Knut Engedal, Norwegian Centre on Aging and Health, Tønsberg and Oslo, Norway
10.20–10.50MRI and CT in dementia diagnostics-old and new methods 
Lars-Olof Wahlund, Karolinska Institutet, Sweden
10.50–11.20Treatment possibilities in next five-ten years: How we have to prepare for that at the clinics?
Jon Snaedal, National University Hospital of Iceland, Iceland
11.20–11.30Discussion
Anne Koivisto and Jon Snaedal
11.30–12.30Lunch, exhibition

Session II: Synucleinopathies: Where are we going?

Chairpersons:  Liisa Myllykangas and Dag Årsland

Time slotPresentation title
12.30–13.00Evidence for two common progression patterns of Lewy-related pathology in the population-based Vantaa85+ study 
Liisa Myllykangas, University of Helsinki, Finland
13.00–13.30Parkinson’s Disease related cognitive impairment
Dag Årsland, King’s College London, UK  and University of Stavanger, Norway
13.30–14.00Pharmacological treatment in LBD – new perspectives
John O’Brien, University of Cambridge, UK
14.00–14.30Fecal microbiota transplantation as a treatment possibility
in synucleinopathies and other neurodegenerative diseases
Filip Scheperjans, University of Helsinki, Finland
14.30–15.00Coffee and tea break, exhibition

Session III: Multidisciplinary Memory disorder meeting at Clinic:
Two cases with neuropsychiatric symptoms on stage

Chairpersons: Johanna Krüger and Peter Høgh

Multidisciplinary team at stage:
• Geriatrician – Anna von Nandelstadh, Geriatric Outpatient Clinic, Helsinki City Hospital, Finland
• Memory nurse – Susanne Kristiansen, Zealand University Hospital, Denmark
• Neurologist – Peter Høgh, University of Copenhagen, Denmark
• Neuropsychologist – Hanna Jokinen-Salmela, Helsinki University Hospital, Finland
• Neuroradiologist – Ritva Vanninen, Kuopio University Hospital, Finland

Time slotPresentation title
15.00–15.20Introduction of the cases with neuropsychiatric symptoms and cognitive deterioration
Chairpersons: Johanna Krüger and Peter Høgh
15.20–16.15Topics to be discussed/presented by multidisciplinary team:
• Social background, environmental factors, FBI-Mod/NPI interview results
• Neurobiology behind neuropsychiatric symptoms
• Fluid and structural biomarkers of neurodegenerative disorders in differential diagnostics: Good or not good?
16.15–16.25Conclusions – Behavioral FTD, AD, VCI or something else? Which features support the diagnosis?
Chairperson Johanna Krüger
16.25–16.50Treatments of frontal symptoms in memory disorders
Risto Vataja, University of Helsinki, Finland
16.50–17.00Closing of the day
Johanna Krüger, Anne Koivisto
17.15–19.15 Patient and Public Involvement (PPI) in Brain Disorders Satellite meeting
20.00–22.00Welcome reception

Day 2 – Wednesday, 24.8.2022:
9th Kuopio Alzheimer Symposium

Opening and Keynote session

Chairpersons: Mikko Hiltunen and Miia Kivipelto

Time slotPresentation title
09.00–09.05Opening words
Mikko Hiltunen, University of Eastern Finland, Finland, Chair of the Organizing Committee
09.05–09.15Welcome address
Jussi Pihlajamäki, Dean of the Faculty of Health Sciences, University of Eastern Finland, Finland
09.15–09.30Welcome address
Philippe Amouyel, University Hospital of Lille, France
09.30–09.45Address from the expert by experience
09.45–10.30Keynote lecture: The Alzheimer Landscape in 2022 and beyond
Philip Scheltens, Alzheimer Center Amsterdam, Amsterdam UMC Netherlands
10.30–11.00Coffee and tea break, exhibition, and posters (odd numbers)

Oral session I: Genetics and personalized medicine in neurodegenerative diseases

Chairpersons: Mikko Hiltunen and Tarja Malm

Time slotPresentation title
11.00–11.25New insights on the genetic etiology of Alzheimer’s and related dementia
Jean-Charles Lambert, INSERM/Institut Pasteur Lille, France
11.25–11.50Outcomes of the genome-wide genetic analyses in MCI
Alfredo Ramirez, University of Cologne, Germany
11.50–12.15Cholesterol and matrisome pathways dysregulated in APOE ε4 human astrocytes
Julia TCW, Boston University School of Medicine, Boston, MA, USA
12.15–12.40Mechanistic elucidation of Alzheimer’s disease using iPSC derived cell models
Jari Koistinaho, University of Helsinki, Finland
12.40–13.05Learning from cognitively healthy centenarians to escape dementia
Henne Holstege, Amsterdam UMC, Netherlands
13.05–13.30Very large-scale biobank projects, experiences from FinnGen
Aarno Palotie, University of Helsinki, Finland
13.30–14.30Lunch, exhibition

Oral session II: New developments in diagnostic and predictive biomarkers in neurodegenerative diseases

Chairpersons: Annakaisa Haapasalo and Henrik Zetterberg

Time slotPresentation title
14.30–14.55Emerging biofluid markers in the diagnostics of dementia
Henrik Zetterberg, University of Gothenburg, Sweden
14.55–15.20Current and future biofluid markers in the differential diagnostics of neurodegenerative diseases
Olivia Belbin, Hospital Santa Creu i Sant Pau, Barcelona, Spain
15.20–15.45Molecular imaging in neurodegenerative diseases
Juha Rinne, Turku PET Center, Turku, Finland
15.45–16.10TMS as a neurophysiological tool in the early differential diagnostics of neurodegenerative diseases
Alberto Benussi, University of Brescia, Brescia, Italy
16.10–16.35Ethical issues related to the clinical use of biomarkers in early neurodegenerative diseases
Gunhild Waldemar, University of Copenhagen, Denmark
16.35–17.15Coffee and tea break, exhibition, and posters (even numbers)
17.15–19.15FinFTD Network Satellite meeting
20.00–22.30Get-together party

Day 2 – Wednesday, 24.8.2022:
3rd Nordic Memory Clinic Conference – NMCC

NMCC Parallel session I (especially targeted for psychologists and congress participants who examine or  use cognitive screening methods in their work)

Place: Auditorio, 2nd floor Music Centre
Chairpersons: Teemu Paajanen and Anne Koivisto

Please note: The parallels 1 and 2 on 24th Aug on-line connection is organized via zoom. The zoom link has been sent via email to the persons who have registered to participate  on-line.

Neuropsychological screening test batteries to detect early cognitive changes in memory disorders:

Time slotPresentation title
11.05–11.25Cognitive assessment in ethnic minority populations
Rune Nielsen, Danish Dementia Research Centre, Denmark
11.25–11.45CERAD – the new Finnish version
Ilona Hallikainen, University of Eastern Finland, Finland
11.45–12.05IFS and FAB screening tests in the evaluation of executive functions
Leena Heikkinen, Oulu University Hospital, Finland
12.05–12.30Novel digital tests for early detection of cognitive impairment,
new findings from Reykjavik and Kuopio studies
Jon Snaedal, National University Hospital of Iceland, Iceland and
Anne Koivisto, Sanna Hannonen, and Sami Andberg, University of Eastern Finland, Finland


Differential diagnostics of cognitive impairment in working age:

Time slotPresentation title
12.30–12.50Neuropsychological assessment in burnout and stress-related illness
Hanna Malmberg-Gavelin, Umeå University, Sweden
12.50–13.10Cognitive symptoms in working-age – diversity of etiologies
Teemu Paajanen, Finnish Institute of Occupational Health Helsinki, Finland
13.10–13.30Cognitive aging and retirement
Linn Elena Zulka, University of Gothenburg, Sweden

NMCC Parallel session II (especially targeted for nurses and other professionals working at memory polyclinics)

Place: Auditorio, 2nd floor Music Centre
Chairperson:  Tarja Välimäki

Please note: The parallels 1 and 2 on 24th Aug on-line connection is organized via zoom. The zoom link has been sent via email to the persons who have registered to participate  on-line.

Time slotPresentation title
14.35–15.15Technological solutions in dementia care
Laila Oksnebjerg, Danish Dementia Research Centre
15.15–15.30Family caregivers evaluation in memory polyclinics- should we evaluate them?
Tarja Välimäki, University of Eastern Finland, Finland
15.45–16.30Teamwork in memory policlinics – added value for care. Experiences from Finland and Iceland
Hanna-Maria Roitto, HUS/University of Helsinki, Elli Uusikoski, Geriatric Outpatient Clinic, Helsinki City Hospital,
and Jon Snaedal and a memory nurse, National University Hospital of Iceland, Iceland

Day 3 – Thursday, 25.8.2022:
9th Kuopio Alzheimer Symposium 24.8.2022–25.8.2022

09.00–10.30Coffee and tea, exhibition
9.50–10.30Posters (odd numbers)

Oral session III: Co-morbidities of neurodegenerative diseases

Chairpersons: Heikki Tanila and Ville Leinonen

Time slotPresentation title
10.30–10.55In vivo human studies of molecular clearance from brain and cerebrospinal fluid in neurodegenerative disease
Per Kristian Eide, Oslo University Hospital, Oslo, Norway
10.55–11.20Targeting Intramural Periarterial Drainage (IPAD) for the treatment of Alzheimer’s disease 
Roxana O. Carare, University of Southampton, UK
11.20–11.45Epilepsy in neurodegenerative disorders
Anita Kamondi, Semmelweis University, Budapest, Hungary
11.45–12.10Potential involvement of varicella zoster virus in Alzheimer’s disease (AD)/ dementia via reactivation of quiescent herpes simplex virus type 1
Ruth Itzhaki, University of Oxford, UK
12.10–12.35Sars-Cov-2 and Alzheimer’s disease
Katja Kanninen, University of Eastern Finland, Kuopio, Finland
12.35–13.35Lunch, exhibition

Oral session IV: New advancements in prevention and therapies of neurodegenerative diseases

Chairpersons: Miia Kivipelto and Tobias Hartmann

Time slotPresentation title
13.35–14.00WW-FINGERS updates: towards personalized prevention and global strategies
Miia Kivipelto, Karolinska Institutet, Stockholm, Sweden and University of Eastern Finland, Kuopio, Finland
14.00–14.25Impact of COVID-19 on prevention strategies
Francesca Mangialasche, Karolinska Institutet, Stockholm, Sweden
14.25–14.50Harmonization and data sharing in prevention studies
Markku Peltonen, THL, Helsinki, Finland
14.50–15.15Multidomain interventions and their novel mechanisms
Tobias Hartmann, Saarland University, Homburg, Germany
15.15–15.40The active role of citizens and patients in dementia prevention
Ana Diaz, Alzheimer Europe
15.40–16.05FINGER-NL: New strategies in multidomain interventions
Wiesje van der Flier, Alzheimer Center Amsterdam, Amsterdam UMC Netherlands
16.05–16.30Coffee and tea break, exhibition, and posters (even numbers)

Closing and award session

Chairpersons: Mikko Hiltunen and Miia Kivipelto

Time slotPresentation title
16.30–16.45Best poster presentation awards
Finnish Alzheimer’s Disease Research Society
16.45–17.00Closing words
Mikko Hiltunen, Miia Kivipelto
19.00–23.00Speakers’ dinner